Difficulty: Medium
Average Score: 83%
Practice
A 58-year-old woman with a history of myasthenia gravis presents to the emergency department complaining of generalized abdominal pain. Her current medications include nifedipine and neostigmine. Her caretaker reports that her bottle of neostigmine is empty but was full earlier in the day. Which of the following findings is likely in this patient?
Correct answer
B
Rationale
In this scenario, the correct answer is B) Constipation. Neostigmine is a cholinesterase inhibitor commonly used in the treatment of myasthenia gravis to increase acetylcholine levels at neuromuscular junctions. However, in this case, the patient's bottle of neostigmine is empty, leading to decreased acetylcholine levels and subsequent cholinergic crisis. Constipation is a common side effect of cholinergic crisis due to excessive stimulation of muscarinic receptors in the gastrointestinal tract.
Option A) Bronchodilation is incorrect because neostigmine would lead to bronchoconstriction rather than bronchodilation due to increased stimulation of muscarinic receptors in the lungs.
Option C) Dizziness is less likely in this case as the primary concern with neostigmine overdose is cholinergic crisis symptoms rather than central nervous system effects like dizziness.
Option D) Hypotension is less likely as neostigmine overdose typically leads to cholinergic crisis symptoms such as increased salivation, lacrimation, urination, and diaphoresis rather than hypotension.
Educationally, this question highlights the importance of monitoring medication adherence and recognizing the potential consequences of abrupt discontinuation of medications, especially those affecting cholinergic pathways. Understanding the side effects and potential complications of medications is crucial in clinical practice to ensure patient safety and optimal outcomes.
Option A) Bronchodilation is incorrect because neostigmine would lead to bronchoconstriction rather than bronchodilation due to increased stimulation of muscarinic receptors in the lungs.
Option C) Dizziness is less likely in this case as the primary concern with neostigmine overdose is cholinergic crisis symptoms rather than central nervous system effects like dizziness.
Option D) Hypotension is less likely as neostigmine overdose typically leads to cholinergic crisis symptoms such as increased salivation, lacrimation, urination, and diaphoresis rather than hypotension.
Educationally, this question highlights the importance of monitoring medication adherence and recognizing the potential consequences of abrupt discontinuation of medications, especially those affecting cholinergic pathways. Understanding the side effects and potential complications of medications is crucial in clinical practice to ensure patient safety and optimal outcomes.